The primary benefit of Olaparib is its targeted approach, which minimizes damage to healthy cells and reduces the side effects commonly associated with traditional chemotherapy. Clinical trials have shown that Olaparib can significantly extend progression-free survival in patients with certain types of cancer, offering a new lease on life for many who have limited treatment options.
